# 合成数据生成在生物医学研究与应用中的综述性研究

发布时间：2025年06月19日

`LLM应用` `生物医学` `数据生成`

> A Scoping Review of Synthetic Data Generation for Biomedical Research and Applications

# 摘要

> 合成数据生成——缓解生物医学领域中的数据稀缺性、隐私担忧及数据质量挑战——得益于大型语言模型（LLMs）的快速发展。这项范围综述遵循PRISMA-ScR指南，综合了2020年至2025年间发表的59项研究，这些研究来自PubMed、ACM、Web of Science和Google Scholar。综述系统性地审视了生物医学研究与合成数据生成的应用趋势，重点聚焦于临床应用、方法论及评估。我们的分析揭示了数据模式中非结构化文本（78.0%）、表格数据（13.6%）和多模态来源（8.4%）；生成方法包括提示工程（72.9%）、微调（22.0%）LLMs及专用模型（5.1%）；以及异质性评估中的内在指标（27.1%）、人工参与评估（55.9%）和基于LLMs的评估（13.6%）。分析解答了健康专业人士在 biomedical 领域如何利用合成数据生成的现状、领域及方法。我们的综述还强调了跨临床领域适应、资源与模型可及性及评估标准化方面的挑战。

> Synthetic data generation--mitigating data scarcity, privacy concerns, and data quality challenges in biomedical fields--has been facilitated by rapid advances of large language models (LLMs). This scoping review follows PRISMA-ScR guidelines and synthesizes 59 studies, published between 2020 and 2025 and collected from PubMed, ACM, Web of Science, and Google Scholar. The review systematically examines biomedical research and application trends in synthetic data generation, emphasizing clinical applications, methodologies, and evaluations. Our analysis identifies data modalities of unstructured texts (78.0%), tabular data (13.6%), and multimodal sources (8.4%); generation methods of prompting (72.9%), fine-tuning (22.0%) LLMs and specialized model (5.1%); and heterogeneous evaluations of intrinsic metrics (27.1%), human-in-the-loop assessments (55.9%), and LLM-based evaluations (13.6%). The analysis addresses current limitations in what, where, and how health professionals can leverage synthetic data generation for biomedical domains. Our review also highlights challenges in adaption across clinical domains, resource and model accessibility, and evaluation standardizations.

[Arxiv](https://arxiv.org/abs/2506.16594)